Atlas Trials

Phase 1 Study of CC-90005 in Healthy Subjects and Subjects With Moderate to Severe Plaque-type Psoriasis

Clinical trial NCT02502188 · TERMINATED

Trial details

NCT number
NCT02502188
Sponsor
Celgene
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
ParapsoriasisHealthy Volunteers
Start date
2015-07-17
Primary completion
2015-11-02
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.